SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002292
Filing Date
2022-08-11
Accepted
2022-08-11 16:38:53
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrkr-20220630x10q.htm   iXBRL 10-Q 1319513
2 EX-10.2 mrkr-20220630xex10d2.htm EX-10.2 224819
3 EX-31.1 mrkr-20220630xex31d1.htm EX-31.1 13829
4 EX-31.2 mrkr-20220630xex31d2.htm EX-31.2 13567
5 EX-32.1 mrkr-20220630xex32d1.htm EX-32.1 6055
6 EX-32.2 mrkr-20220630xex32d2.htm EX-32.2 6061
7 GRAPHIC mrkr-20220630x10q002.jpg GRAPHIC 51317
8 GRAPHIC mrkr-20220630x10q001.jpg GRAPHIC 9834
  Complete submission text file 0001410578-22-002292.txt   5740368

Data Files

Seq Description Document Type Size
9 EX-101.SCH mrkr-20220630.xsd EX-101.SCH 45983
10 EX-101.CAL mrkr-20220630_cal.xml EX-101.CAL 39268
11 EX-101.DEF mrkr-20220630_def.xml EX-101.DEF 128459
12 EX-101.LAB mrkr-20220630_lab.xml EX-101.LAB 286445
13 EX-101.PRE mrkr-20220630_pre.xml EX-101.PRE 254477
66 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20220630x10q_htm.xml XML 889998
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 221156494
SIC: 2834 Pharmaceutical Preparations